Segall Bryant & Hamill’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.2M | Sell |
310,830
-32,341
| -9% | -$1.68M | 0.23% | 154 |
|
2025
Q1 | $21.9M | Sell |
343,171
-9,932
| -3% | -$634K | 0.34% | 96 |
|
2024
Q4 | $16.9M | Sell |
353,103
-2,073
| -0.6% | -$99.1K | 0.23% | 132 |
|
2024
Q3 | $20.3M | Buy |
355,176
+49,856
| +16% | +$2.85M | 0.28% | 111 |
|
2024
Q2 | $16M | Buy |
305,320
+35,360
| +13% | +$1.85M | 0.28% | 115 |
|
2024
Q1 | $11M | Buy |
269,960
+27,490
| +11% | +$1.12M | 0.21% | 169 |
|
2023
Q4 | $8.96M | Buy |
242,470
+24,065
| +11% | +$889K | 0.17% | 200 |
|
2023
Q3 | $8.34M | Sell |
218,405
-44,683
| -17% | -$1.71M | 0.1% | 242 |
|
2023
Q2 | $9.49M | Buy |
263,088
+77,586
| +42% | +$2.8M | 0.1% | 242 |
|
2023
Q1 | $7.08M | Sell |
185,502
-1,352
| -0.7% | -$51.6K | 0.08% | 285 |
|
2022
Q4 | $10.6M | Sell |
186,854
-3,853
| -2% | -$219K | 0.12% | 210 |
|
2022
Q3 | $7.54M | Buy |
+190,707
| New | +$7.54M | 0.09% | 254 |
|
2018
Q1 | – | Sell |
-13,400
| Closed | -$271K | – | 612 |
|
2017
Q4 | $271K | Hold |
13,400
| – | – | 0.01% | 508 |
|
2017
Q3 | $233K | Hold |
13,400
| – | – | 0.01% | 532 |
|
2017
Q2 | $172K | Hold |
13,400
| – | – | ﹤0.01% | 541 |
|
2017
Q1 | $174K | Sell |
13,400
-20,000
| -60% | -$260K | ﹤0.01% | 535 |
|
2016
Q4 | $330K | Buy |
+33,400
| New | +$330K | 0.01% | 460 |
|
2014
Q2 | – | Sell |
-11,000
| Closed | -$140K | – | 565 |
|
2014
Q1 | $140K | Buy |
+11,000
| New | +$140K | ﹤0.01% | 563 |
|